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Halichondria okadai (Japanese black sponge), and its antimicrobial and 
cytotoxic anticancer effects
Abstract:
Abstract
We studied localization and physiological activities of a lectin showing specific binding 
to N-acetylhexosamines, termed HOL-18, purified from Japanese black sponge (Halichondria 
okadai). Antiserum against the lectin was generated in rabbit and applied for 
immunohistochemical analyses. HOL-18 was expressed specifically around water pores and on 
spicules of sponge tissues. It showed strong binding to a variety of N-acetylhexosamines: N-
acetyl D-glucosamine, N-acetyl D-galactosamine, N-acetyl mannosamine, N-acetyl muramic 
acid, and N-acetyl neuraminic acid. Hemagglutination induced by the lectin was inhibited by 
lipopolysaccharides and a peptidoglycan. HOL-18 inhibited growth of a gram-positive 
bacterium (Listeria monocytogenes), gram-negative bacteria (Escherichia coli, Shigella boydii, 
Pseudomonas aeruginosa), and a fungus (Aspergillus niger). It displayed anti-biofilm activity 
against P. aeruginosa. HOL-18 was internalized into conidiophores of A. niger, and displayed 
notable antifungal activity. Fluorescence microscopy revealed binding and incorporation of the 
lectin into human cancer cell lines HeLa, MCF-7, and T47D, but not Caco-2. HOL-18 displayed 
dose-dependent cytotoxic effects against HeLa, MCF-7, and T47D, with respective IC50 values 
40, 52, and 63 μg/mL. In HeLa cells, it activated phosphorylation of MAPK pathway molecule 
(ERK1/2) and activated caspase-3 to trigger apoptosis. HOL-18 thus has the potential to 
upregulate metabolic pathways in higher animal cells through binding to N-
acetylhexosamines.
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2Abstract
We studied localization and physiological activities of a lectin showing specific binding to N-
acetylhexosamines, termed HOL-18, purified from Japanese black sponge (Halichondria okadai). 
Antiserum against the lectin was generated in rabbit and applied for immunohistochemical analyses. 
HOL-18 was expressed specifically around water pores and on spicules of sponge tissues. It showed 
strong binding to a variety of N-acetylhexosamines: N-acetyl D-glucosamine, N-acetyl D-
galactosamine, N-acetyl mannosamine, N-acetyl muramic acid, and N-acetyl neuraminic acid. 
Hemagglutination induced by the lectin was inhibited by lipopolysaccharides and a peptidoglycan. 
HOL-18 inhibited growth of a gram-positive bacterium (Listeria monocytogenes), gram-negative 
bacteria (Escherichia coli, Shigella boydii, Pseudomonas aeruginosa), and a fungus (Aspergillus 
niger). It displayed anti-biofilm activity against P. aeruginosa. HOL-18 was internalized into 
conidiophores of A. niger, and displayed notable antifungal activity. Fluorescence microscopy 
revealed binding and incorporation of the lectin into human cancer cell lines HeLa, MCF-7, and 
T47D, but not Caco-2. HOL-18 displayed dose-dependent cytotoxic effects against HeLa, MCF-7, 
and T47D, with respective IC50 values 40, 52, and 63 μg/mL. In HeLa cells, it activated 
phosphorylation of MAPK pathway molecule (ERK1/2) and activated caspase-3 to trigger apoptosis. 
HOL-18 thus has the potential to upregulate metabolic pathways in higher animal cells through 
binding to N-acetylhexosamines.
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31. Introduction
Sponges (phylum Porifera) are the most primitive group of multicellular animals, and the 
phylogenetically oldest metazoan phylum. Sponges have a simple body plan, but fairly complex 
genome structure [1]. The genetic diversity of sponges allows them to express various types of 
glycans (monosaccharide chains) [2-5] involved in biological functions such as cellular structure 
determination [2], cell agglutination [3, 4], and inhibition of nitric oxide production [5]. Numerous 
lectins (glycan-binding proteins), belonging to several structural families, are also found in sponges [6, 
7]. These lectins play important roles in innate immunity [8], cytotoxicity [9], and development of 
metazoan body plan [10]. The presence of lectins in various sponge species is well documented; 
however, little is known regarding lectin expression in specific tissues [11-13].
We previously isolated and characterized a lectin termed HOL-18 from Japanese black sponge 
(Halichondria okadai) [14]. HOL-18, a tetramer glycoprotein consisting of 18-kDa polypeptides, 
bound specifically to N-acetylhexosamines containing N-acetyl D-glucosamine (GlcNAc) and N-
acetyl D-galactosamine (GalNAc), and induced cytotoxicity against lymphoma cell lines K562 and 
Jurkat [14]. Many lectins extracted from marine invertebrates have been found to display regulatory 
effects on mammalian cancer cells [15-18], including activation of metabolic pathways involved in 
regulation of cell growth [15-17] and differentiation [18]. Few previous studies have addressed 
mechanisms whereby N-acetylhexosamine-binding sponge lectins affect growth or differentiation of 
mammalian cells.
Numerous species of bacteria and fungi produce biofilms, i.e., self-generated matrices composed 
of extracellular biomolecules (e.g., glycans) and macromolecules (e.g., proteins and nucleotides). 
Surface glycans of peptidoglycans and lipopolysaccharides present on bacterial and fungal cell walls 
include N-acetylhexosamines such as GlcNAc, GalNAc, N-acetyl mannosamine (ManNAc), N-acetyl 
muramic acid (MurNAc), and N-acetyl neuraminic acid (NeuAc) [19, 20]. These sugars play key roles 
in production of biofilm and its regulation by quorum-sensing [21], i.e., a cell-density-dependent 
signaling system, mediated by small, diffusible, autoinducer molecules, that helps regulate bacterial 
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4colony formation in response to environmental changes [22]. Biofilm formation by pathogenic 
microorganisms is often correlated with multidrug resistance [23, 24]. If surface glycans help control 
bacterial growth and biofilm formation, they may provide a basis for inhibition of multidrug 
resistance.
Many invertebrate lectins function as self-defense molecules or play roles in innate immune 
responses, e.g., self vs. non-self recognition at cellular and molecular levels. The present study was 
designed to elucidate antimicrobial and cytotoxic anticancer effects of HOL-18, and the underlying 
mechanisms. Our findings provide a useful basis for further investigation of physiological properties 
and effects of N-acetylhexosamine-binding lectins in vertebrates and invertebrates.
2. Materials and methods
2.1. Materials
H. okadai specimens were collected from the tidal zone of Zushi coast, Kanagawa Prefecture, 
Japan, and stored at -80 °C until study. Strains of four bacteria (Escherichia coli, Pseudomonas 
aeruginosa, Shigella boydii, Listeria monocytogenes) and one fungus (Aspergillus niger) were 
obtained from the Dept. of Biochemistry and Molecular Biology, University of Rajshahi, Bangladesh. 
Human cell lines HeLa (cervical cancer), MCF-7 (breast cancer), T47D (breast cancer), and Caco-2 
(colon cancer) were from ATCC. GlcNAc, GalNAc, ManNAc, MurNAc, NeuAc, glucosamine (GlcN), 
galactosamine (GalN), lipopolysaccharides (from E. coli and P. aeruginosa), peptidoglycan (from 
Micrococcus luteus), bovine serum albumin (BSA), Pathoprep-568, cell lysis buffer M, Mayer’s 
hematoxylin solution, eosin alcohol solution, 4% paraformaldehyde phosphate buffer, 20% 
glutaraldehyde solution, cacodylate buffer, Canada balsam, crystal violet solution, Penicillin-
Streptomycin solution, and horseradish peroxidase (HRP)-conjugated β-actin mAb were from 
FUJIFILM Wako Pure Chemical Corp. (Osaka, Japan). Chitin was from Nacalai Tesque Inc. (Kyoto, 
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5Japan). Standard protein markers for SDS-PAGE were from Takara Bio Inc. (Kyoto). HRP-
conjugated goat anti-rabbit IgG was from Tokyo Chemical Industry Co. (Tokyo, Japan). FITC-labeled 
goat anti-rabbit IgG was from Abcam (Cambridge, UK). Anti-Erk1 and anti-phosphorylated Erk1/2 
(pT202/pY204) mAbs were from Becton Dickinson (Franklin Lakes, NJ, USA). Anti-caspase-3 mAb 
was from Cell Signaling Technology (Danvers, MA, USA). Can Get Signal Immunoreaction 
Enhancer solutions A and B were from Toyobo Co. (Osaka). 4’,6-diamidino-2-phenylindole 
(DAPI), RPMI 1640 medium, and fetal bovine serum (FBS) were from Gibco/ Thermo Fisher 
(Waltham, MA, USA). Poly-L-lysine-coated slides were from MilliporeSigma (Darmstadt, Germany). 
Cell Counting Kit-8 (including WST-8[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium monosodium salt]), FITC Labeling kit-NH2, and HiLyte555 Labeling 
kit-NH2 were from Dojindo Laboratories (Kumamoto, Japan). PVDF membrane for electroblotting 
and peroxidase substrate EzWestBlue were from ATTO Corp. (Tokyo).
2.2. Purification and molecular determination of lectin HOL-18
HOL-18 was purified from stored H. okadai specimens as described previously [14], with slight 
modification. Specimens were homogenized with 10 volumes (w/v) Tris-buffered saline (TBS) (10 
mM tris(hydroxymethyl)aminomethane-HCl and 150 mM NaCl, pH 7.4). Homogenates were filtered 
through gauze and centrifuged (model Suprema 21, TOMY Co.; Tokyo) at 27,500 × g for 1 h at 4 °C. 
Crude supernatant was applied onto a chitin-packed column (5 mL), which was then washed with 
TBS. HOL-18 was eluted with 20 mM D-GlcNAc in TBS, and its purity was evaluated by SDS-
PAGE [25] using 15% (w/v) acrylamide gel under reducing condition. The gel was stained by CGP 
method [26]. Protein was quantified using bicinchoninic acid protein assay kit with BSA as standard 
protein. Absorbance was measured at 562 nm using a 96-well microplate photoreader (SmartSpec 
3000, Bio-Rad Laboratories; Hercules, CA, USA) [27, 28].
2.3. Generation of antiserum and evaluation of anti-HOL-18 antibody specificity
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6Antiserum against HOL-18 was raised in rabbit serum by Medical and Biological Laboratory Inc. 
[MBL], Nagoya, Japan. Antigen (500 μg purified HOL-18) was injected 3x during 20 days, and 
antiserum was collected using saturated NH3SO4. Crude sponge extract and purified HOL-18 
separated by SDS-PAGE were electroblotted onto PVDF membrane [29]. Blotted membrane was 
masked with TBS containing 1% (w/v) BSA, soaked with 0.2% Triton X-100 at room temperature 
(RT), applied with anti-HOL-18 rabbit serum (1:1000 dilution) (primary antibody) and HRP-
conjugated goat anti-rabbit IgG (secondary antibody) for 1 h each, and colored with EzWestBlue as 
per the manufacturer's instructions.
2.4. Localization of HOL-18 in sponge tissues
Sponge tissues were excised, fixed in 4% paraformaldehyde with 0.1% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4) for 2 h at 4 °C, dehydrated by ethanol dilution series, and embedded in 
Pathoprep-568. Sections were cut by microtome, mounted on poly-L-lysine-coated slides, 
deparaffinized by immersion in xylene, dehydrated ethanol, and ethanol dilution series, blocked 
overnight with 1% (w/v) BSA containing TBS, applied with anti-HOL-18 antiserum (diluted 1:500 
with TBS) and FITC-labeled anti-rabbit goat IgG for 1 h, counterstained with hematoxylin-eosin, 
mounted in Canada balsam, and observed by fluorescence microscopy (λex/em＝ 495/520 nm).
2.5. Sugar-binding specificity of HOL-18
Binding specificities of HOL-18 to N-acetyl sugars (prepared at concentration 200 mM) and their 
glycoconjugate derivatives (prepared at concentration 1 mg/mL) were estimated using 96-well V-
bottom plates. Twenty μL of each solution was serially diluted in TBS, mixed with 20 μL lectin 
solution (previously adjusted to titer 16 [30]), trypsinized, and applied to glutaraldehyde-fixed rabbit 
erythrocytes in TBS containing 0.2% Triton X-100. Each plate was kept at RT for 1 h to form a dot 
(no agglutination; inhibited; effective) or sheet (agglutination; not inhibited; ineffective) at the bottom. 
For each saccharide, minimum concentration at which dot turned into sheet was defined as binding 
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
7affinity to HOL-18.
2.6. Bacteriostatic assay
Bacteriostatic assays were performed as in our previous studies [31, 32]. Gram-negative (E. coli, 
P. aeruginosa, S. boydii) and Gram-positive bacteria (L. monocytogenes) were grown overnight in LB 
medium, harvested, and washed with phosphate-buffered saline (PBS). Fifty μL bacterial suspension 
(turbidity adjusted to OD600 = 0.6) in PBS was mixed with serial dilution of HOL-18 for quantitative 
assay. Bacterial suspension was washed, and OD600 adjusted to 1.0. Bacteria were mixed with HOL-
18 to final concentrations 6.25, 12.5, 25, 50, 100, and 200 μg/mL in 96-well flat-type microtiter plates, 
and cultured at 37 ºC, with OD600 measured every 4 h. Growth suppressive activity (%) of HOL-18 
was calculated as (1 - [OD600 experiment/OD600 control]) × 100%.
2.7. Anti-biofilm activity of HOL-18
Anti-biofilm activity was evaluated as in our previous study [32]. E. coli and P. aeruginosa were 
grown in nutrient broth for 24 h at 30 ºC. Colonies were transferred into test tubes and centrifuged at 
3500 × g for 3 min. Turbidity of bacterial cell suspensions was adjusted to OD640 = 1.0. Fifty μL 
bacterial suspension was mixed with serial dilution of purified lectin (final volume 100 μL) in 96-well 
microtiter plate, and incubated for 24 h at 37 °C.
Biofilm in each well was stained by exposure to 20 μL of 0.1% (w/v) crystal violet solution 
(filtered through pore size 0.45 μm filter paper) for 10 min at RT. Each well was washed 3x with TBS 
to remove free dye, then treated with 150 μL of 95% ethanol for 10 min at RT to release crystal violet. 
Extracted dye was transferred to another 96-well plate, and OD640 values were recorded by automated 
microtiter plate reader at 640 nm. Percentage reduction of biofilm formation resulting from lectin 
treatment, relative to control, was calculated as:
% reduction of biofilm formation = (1 - [OD640 experiment/OD640 control]) × 100%
In another experiment, P. aeruginosa were grown overnight at 37 ºC, centrifuged at 3000 × g for 3 
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8min, and turbidity was adjusted to OD640 = 1.0. There were five experimental test tubes, containing: (i) 
liquid nutrient medium (2 mL) only (negative control); (ii) bacteria only (positive control); (iii) 
bacteria added with 50 μg/mL HOL-18; (iv) bacteria added with 200 μg/mL HOL-18; (v) bacteria 
added with 200 μg/mL HOL-18 plus 20 mM GlcNAc. Tubes were kept at RT for 48 h to allow 
biofilm formation.
2.8. Internalization of HOL-18 into fungal mycelia, and its antifungal activity
HOL-18 was labeled using HiLyte555 labeling kit as per the manufacturer's instructions. Fungal 
(A. niger) mycelia were grown in sterile petri dishes (100×15 mm) containing 30 mL potato dextrose 
agar, and treated with HiLyte555-labeled HOL-18 (25 μg/mL) for 2 h at 37 °C. Cells were fixed, and 
plasma membranes permeabilized with paraformaldehyde and observed by fluorescence microscopy 
(λex/em＝ 550/566 nm) (model iX71, Olympus Corp.; Tokyo).
Antifungal activity of HOL-18 against A. niger was assayed by agar disc diffusion method [32]. A. 
niger were grown as described above, and mycelia were placed on the dish along with sterile filter discs. 
Three discs were soaked, respectively, with 100 μL HOL-18 (100 μg/mL), HOL-18 + 20 mM GlcNAc, 
and HOL-18 + 20 mM TBS. Petri dishes were incubated at 30 ºC until occurrence of mycelial growth 
and formation of crescent-like transparent zones surrounding the discs.
2.9. Internalization of HOL-18 and its cytotoxic effect on cultured cancer cells
HOL-18 was labeled by FITC-labeling kit as per the manufacturer's instructions. Cancer cell 
lines HeLa, MCF-7, T47D, and Caco-2 were cultured and maintained in RPMI 1640 supplemented 
with heat-inactivated FBS (10%, v/v), penicillin (100 IU/mL), and streptomycin (100 μg/mL) at 37 °C 
in 95% air/ 5% CO2 atmosphere. Cells were washed 3× with PBS, incubated 2 h with 25 μg/mL 
FITC-labeled HOL-18, nuclei stained by DAPI, and cells fixed with 4% paraformaldehyde and 
observed by fluorescence microscopy (λex/em＝495/520 nm for FITC; 364/454 nm for DAPI).
Cytotoxic activities of HOL-18 (concentrations ranging from 0-100 μg/mL) against the cancer 
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9cell lines were determined using Cell Counting Kit-8 containing WST-8 ("WST-8 assay") [15]. IC50 
values were generated from dose-response curves for each cell line. Inhibition of HOL-18 (50 μg/mL) 
cytotoxic effect on HeLa cells was evaluated in the co-presence of sugars (Glc, GlcNAc, Man, 
ManNAc; each 20 mM) to assess cell viability.
2.10. Detection of activated signal transduction molecules and their phosphorylated forms in 
HeLa cells in the presence of HOL-18
Cervical cancer cell line HeLa (3×105 cells) was cultured with HOL-18 (0-100 μg/mL) for 24 h, 
and lysed with 200 μL cell lysis buffer M. Cell lysate was separated by SDS-PAGE and electroblotted 
onto PVDF membrane. Primary antibodies used were directed to ERK (extracellular signal-regulated 
kinase)1 (mouse mAb; dilution 1:3000), phospho-ERK1/2 (mouse mAb; dilution 1:3000) and 
caspase-3 (rabbit mAb; dilution 1:5000). Membrane was masked with TBS containing 1% BSA, 
soaked with 2% Triton X-100 at RT, incubated with HRP-conjugated goat anti-mouse IgG (for mouse 
mAb) or anti-rabbit IgG (for rabbit mAb) for 1 h [15], and colored with EzWestBlue. Experiments 
were performed in triplicate.
2.11. Statistical analysis
For each studied parameter, experimental results were presented as mean ± standard error (SE) 
for three replicates. Data were subjected to one-way analysis of variance (ANOVA) followed by 
Dunnett's test, using SPSS Statistics software package, v. 10 (www.ibm.com/products/spss-statistics). 
Differences with p< 0.05 were considered significant.
3. Results
3.1. Generation of antiserum against HOL-18
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Anti-HOL-18 antiserum raised in rabbit was identified by western blotting analysis (Fig. 1). A 
band with molecular mass 18,000 was detected in crude extract of H. okadai by addition of HRP-
conjugated goat anti-rabbit IgG and Coomassie Brilliant Blue staining (Fig. 1, column A). 
Localization of HOL-18 in sponge tissues was assessed using this antiserum.
3.2. Localization of HOL-18 around water pores and spicules in sponge tissues
HOL-18 signals detected by the antiserum indicated its specific presence around large water 
pores (Fig. 2A) and on spicules (Fig. 2C), whereas its expression in parenchyma cells was low. 
Higher magnification revealed the presence of HOL-18 inside water pores (Fig. 2E). Our previous 
study [14] similarly revealed high concentration (7.5 μg/g wet volume) of HOL-18 around water 
pores and spicules in sponge tissues.
3.3. Binding of HOL-18 to a variety of N-acetyl sugars
Binding specificities of HOL-18 to various N-acetyl sugars are summarized in Table 1. 
Hemagglutinating activity of the lectin was inhibited by addition of D-ManNAc (6.25 mM), D-
MurNAc (12.5 mM), D-NeuAc (25 mM) (present study), and D-GlcNAc (3.13 mM) [14], indicating 
the essential role of N-acetyl residue. HOL-18 had broad sugar-binding specificity, whereas lectin 
iNoL, purified from Ibacus novemdentatus (slipper lobster) serum, was specific to D-ManNAc [16]. 
Hemagglutinating activity was also inhibited by E. coli (125 μg/mL) and P. aeruginosa (250 μg/mL) 
lipopolysaccharides, and by peptidoglycan (250 μg/mL). Thus, HOL-18 recognizes a wide variety of 
N-acetyl sugars and glycoconjugates that express such sugars.
3.4. Bacteriostatic and anti-biofilm activities of HOL-18
Planktonic growth of E. coli, S. boydii, and L. monocytogenes was inhibited by HOL-18 in dose-
dependent manner. At concentration 200 µg/mL, the lectin displayed growth suppressive activity of 
45% against E. coli, 42% against S. boydii, and 40% against L. monocytogenes (Fig. 3A, black, gray, 
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and striped bars, respectively), but only 12% against P. aeruginosa (white bars). Presence of the lectin 
strongly inhibited biofilm formation in P. aeruginosa (Fig. 3B, solid line), despite its negligible effect 
on growth. Anti-biofilm activity of HOL-18 was blocked by co-presence of GlcNAc (Fig. 3B, dotted 
line). We previously reported similar reduction of P. aeruginosa biofilm formation by StL, another N-
acetylhexosamine-binding lectin extracted from potato (Solanum tuberosum) cultivar [32]. We were 
able to visibly demonstrate the anti-biofilm activity of HOL-18. In these experiments, P. aeruginosa 
biofilm formation was reduced by HOL-18 in dose-dependent manner (Fig. 3C, panels c and d), and 
this effect was blocked by GlcNAc (panel e).
3.5. Internalization and antifungal activity of HOL-18
HiLyte555-labeled HOL-18 was internalized into conidiophores of A. niger, where it damaged 
the tube-like structure (Fig. 4A, yellow triangles). HOL-18 at concentration 50 μg/mL exerted notable 
antifungal activity through development of a clear zone (Fig. 4B, "L"), and this effect was blocked by 
co-presence of GlcNAc ("S"). We obtained similar results for potato lectin StL in a previous study 
[32].
3.6. Internalization and cytotoxic effects of HOL-18 on cultured cancer cell lines
FITC-labeled HOL-18 was internalized into HeLa (cervical), MCF-7 (breast), and T47D (breast) 
cancer cells (Fig. 5A, B, C). Strong fluorescence inside cells was detected because of FITC-HOL-18 
incorporation. HOL-18 appeared to be stored in vesicles surrounding nuclei (Fig. 5B), in addition to 
its localization around fibrous structures (Fig. 5A, C). We previously made similar observations for 
internalization of iNoL from slipper lobster [16]. H.L. Monaco's group described similar 
internalization of BEL, a TF-antigen-binding, R-type lectin derived from the mushroom Boletus 
edulis [33]. HOL-18 was not notably internalized into Caco-2 (colon cancer) cells (Fig. 5D).
HOL-18 displayed dose-dependent cytotoxic effects against HeLa, MCF-7, and T47D (Fig. 6A, 
striped, black, and white columns), with respective IC50 values 40, 52, and 63 μg/mL. In contrast, it 
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had no effect on growth of Caco-2 (dotted column). Thus, cytotoxicity of HOL-18 appeared to be 
closely related to its internalization. The cytotoxic effect of 50 μg/mL HOL-18 on HeLa was more 
strongly inhibited by N-acetylhexosamines (GlcNAc, ManNAc) than by corresponding simple sugars 
(Glc, Man) (Fig. 6B).
3.7. Expression of activated signal transduction molecules and their phosphorylated forms in 
HeLa cells in the presence of HOL-18
MAPK pathway of extracellular signal-regulated kinase (ERK)1/2 signaling cascade in HeLa 
was activated by HOL-18 in dose-dependent manner, as shown by western blotting (Fig. 7, P-
ERK1/2 vs. ERK1). HOL-18 also induced activation of caspase-3 (Fig. 7, Pro-caspase-3 vs. Cleaved 
caspase-3). These findings indicate the ability of HOL-18 to induce cellular regulation through 
MAPK pathway, including ERK and caspase-3 activation. HOL-18 present in sponge (H. okadai) 
therefore has the potential to upregulate metabolic pathways in higher animal cells through 
binding to N-acetylhexosamines.
4. Discussion
Sponges, which are sessile marine filter feeders, have developed efficient defense mechanisms 
against foreign invaders such as viruses, bacteria, and eukaryotic organisms [34]. A specific 18-kDa 
polypeptide was detected by antiserum raised against HOL-18 in crude sponge tissue extract on 
PVDF membrane. Immunohistochemical analysis of H. okadai (family Halichondriidae) body tissue 
sections revealed expression of the lectin on spicules, and around or inside water pores (Fig. 2). 
Localization of HOL-18 was very different from that of another N-acetylhexosamine-binding lectin 
isolated from the sponge Axinella corrugata (family Axinellidae), which was found in large 
cytoplasmic granules inside spherule cells [11]. HOL-18 localization was somewhat similar to that of 
a galectin in another demosponge species, Suberites domuncula (family Suberitidae) [35]. This 
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galectin was shown to coexist with collagen and silicatein, the main silicate-promoting protein in 
spicules, which provides strength [13]. HOL-18, although differing from galectin in regard to glycan-
binding specificity, may conceivably play a similar role in biomineralization of spicules. 
Transcriptomic studies of H. okadai will help clarify the physiological functions of HOL-18.
The observed antibacterial activity of HOL-18 (Fig. 3) suggests that this lectin may function as a 
self-defense molecule against gram-positive and/or gram-negative bacteria, since it is present around 
water pores in H. okadai. Antibacterial activities have been reported for numerous other sponge 
lectins isolated to date [36-39]. HOL-18 did not strongly inhibit planktonic growth of P. aeruginosa, 
but did reduce biofilm formation in dose-dependent manner. This activity was blocked by GlcNAc, 
indicating involvement of the carbohydrate recognition domain (CRD) of the lectin in anti-biofilm 
activity. Similar anti-biofilm activity of sponge lectins was reported recently by A.H. Sampaio's group 
[37, 40]. We also observed reduction of P. aeruginosa biofilm formation by GlcNAc-binding potato 
lectin StL [32] (see Secs. 3.4 and 3.5). These findings indicate that N-acetylhexosamine-binding 
lectins have strong potential to inhibit biofilm formation by numerous types of bacteria. 
All microorganisms express surface-exposed carbohydrates as potential specific lectin-reactive 
sites. HOL-18 displayed differential responses to different types of bacteria, and was involved in 
antibacterial defenses through disruption of their biofilms, based on recognition of various 
carbohydrates. The nature of HOL-18 binding to lipopolysaccharides and a peptidoglycan (Table 1) 
was similar to that of another GlcNAc-binding lectin, from S. domuncula, which became 
overexpressed in response to lipopolysaccharide treatment and displayed antibacterial activity [41]. 
Biofilm-forming bacteria such as P. aeruginosa sometimes develop multidrug resistance, and are a 
steadily increasing threat to human health. Some previous studies on mechanisms of multidrug 
resistance have focused on modulation of glycans [42, 43]. Results of the present study suggest that 
N-acetylhexosamine-binding lectins have the potential to block or inhibit biofilm formation through 
matrix dissociation based on glycan-lectin interaction.
A remarkable feature of HOL-18 is its internalization into fungi and human cancer cells (Figs. 
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4A, 5). Previous studies have shown that various lectins from marine invertebrates can become 
incorporated into and regulate eukaryotic cells [44, 45]. HOL-18 at concentration 1 mg/mL killed A. 
niger in glycan-dependent manner, although the mechanism of this antifungal activity is unclear. One 
possibility is that HOL-18 binds to chitin or other saccharides on the fungal cell wall, and then 
becomes internalized and interferes in processes of nutrient absorption or spore germination, as 
proposed for CGL [46], a lectin from the mussel Crenomytilus grayanus that displays antifungal 
activity. 
HOL-18 internalized into and inhibited growth of human cancer cell lines HeLa, MCF-7, and 
T47D, but not Caco-2. HOL-18 showed greatest cytotoxicity against HeLa; this effect was dose-
dependent, and IC50 value was 40 μg/mL. Lectins from the sponges Haliclona cratera and 
Cinachyrella apion showed even greater cytotoxicity against HeLa; IC50 values in these cases were 
respectively 9 and 10 μg/mL [9, 47]. A lectin from Haliclona caerulea reduced MCF-7 viability with 
IC50 = 100 μg/mL, whereas HOL-18 showed IC50 = 52 μg/mL against MCF-7 [45]. HOL-18 did not 
bind to nor show cytotoxic effect against Caco-2. Similarly, GlcNAc-specific lectins from rice bran 
had no cytotoxic effect on Caco-2 even at concentration 200 μg/mL [48]. Results of the present study 
indicate a connection between internalization and cytotoxicity of HOL-18 in fungi and cancer cells, 
which provides a clue to its mechanism of action.
HOL-18 activated several metabolic pathways through its binding to glycans. Activation of ERK 
and caspase-3 pathways by HOL-18 showed some similarity to function of MytiLec-1, a cytotoxic 
mussel lectin with binding specificity to α-Gal [15]. These findings suggest that lectins that induce 
signal transduction events show effective selection of surface glycan ligands to trigger common 
metabolic pathways and apoptosis. P.A. Videira's group found that the GalNAc-binding lectin 
halilectin-3 induced apoptosis and autophagy in MCF-7 through caspase-9 activation and protein LC3 
expression [45]. Halilectin-3 showed binding specificity to GlcNAc and ManNAc, in contrast to the 
broader sugar-binding specificity of HOL-18, and it was involved in different cellular regulatory 
processes. Findings from these studies, taken together, demonstrate that (i) N-acetylhexosamines 
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interact with a variety of exogenous lectins produced by lower marine invertebrates, and (ii) multiple 
mechanisms involving glycans and lectins trigger various metabolic regulatory systems through series 
of signal transduction molecules.
Conclusions
N-acetylhexosamine is a common sugar, found in organisms ranging from bacteria to humans, 
synthesized from fructose-6-phosphate via glucosamine-6-phosphate [49]. It plays essential roles as a 
skeletal component [50], in signal transduction [51, 52], anti-cancer mechanisms [53], and many other 
basic physiological processes. We found that the novel N-acetylhexosamine-binding lectin HOL-18 is 
localized around water pores and spicules of the Japanese black sponge Halichondria okadai. It binds 
to bacteria and fungi to exert antibacterial and anti-biofilm activities as a self-defense molecule. 
Various toxins produced by invertebrates have been shown to affect mammalian cells [54]. In 
experiments with cultured human cells, HOL-18 administration was found to inhibit proliferation of 
tumor cells with surface expression of N-acetylhexosamine-containing sugar chains. Binding of HOL-
18 to these sugar chains induced activation of intracellular signaling. Such growth suppressive activity 
of HOL-18 against human cancer cells may mimic defense mechanisms in sponges against invaders, 
and thus facilitate discovery of synchronous relationships among animal evolutionary processes and 
human diseases. Such knowledge is relevant to next-generation development of lectins derived from 
marine invertebrates as clinical drugs.
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Figure legends
Fig. 1. Detection of HOL-18 in H. okadai. Crude sponge extract was separated by SDS-PAGE 
and transferred to a membrane (A). HOL-18 (asterisk) in crude extract was detected by peroxidase 
staining of HRP-conjugated goat anti-rabbit IgG raised against HOL-18. Bands in crude extract (B) 
and purified HOL-18 (C) were stained by Coomassie Brilliant Blue G-250. Numbers at left: 
molecular mass (×1,000) standard (St).
Fig. 2. Localization of HOL-18 in sponge tissue. Paraffin-embedded serial sections were 
immunostained with antiserum against HOL-18 (A-E) and rabbit pre-immune serum (F), followed by 
FITC-conjugated secondary antibody, and observed by fluorescence microscopy (A, C, E, F; λex/em＝ 
495/520 nm) and phase-contrast microscopy (B, D, G). G: hematoxylin-eosin staining. Scale bars: 
100 μm (white) and 300 μm (black), respectively.
Fig. 3. Bacteriostatic and anti-biofilm activities of HOL-18. A: Bacteriostatic activity. Black, 
gray, striped, and white columns indicate growth reduction of S. boydii, L. monocytogenes, E. coli, 
and P. aeruginosa, respectively. Error bars: SE from three independent experiments (replicates). Data 
shown are mean ± SE (n= 3). *p< 0.05. B: Anti-biofilm activity. P. aeruginosa was cultured for 24 h 
with various HOL-18 concentrations (0-200 μg/mL) in 96-well plates in the presence (dotted line) or 
absence (solid line) of haptenic sugar GlcNAc (20 mM). C: Visible reduction by HOL-18 of P. 
aeruginosa biofilm formation. P. aeruginosa was cultured in glass tubes for 48 h. (a) Culture medium 
alone (negative control; no bacteria or HOL-18). (b) Biofilm formation by bacteria alone (no HOL-
18). (c) Bacteria with 50 μg/mL HOL-18. (d) Bacteria with 200 μg/mL HOL-18. (e) Bacteria with 200 
μg/mL HOL-18 and 20 mM GlcNAc.
Fig. 4. A: Internalization of HOL-18 into A. niger mycelia. Cells were treated with HiLyte555-
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labeled HOL-18 (25 μg/mL) for 2 h at 37 °C and observed by fluorescence microscopy. Fungi were 
observed by fluorescence microscopy (a and c; λex/em＝550/566 nm) and phase-contrast microscopy (b 
and d). Yellow triangles indicate same positions of accumulating HOL-18. Scale bar: 25 μm. B: 
Growth inhibition of fungi (on discs) by HOL-18. Arrow: transparent zone (fungi killed by HOL-18). 
C: control disc (soaked with TBS medium only). L: disc with 50 μg/mL HOL-18. S: disc with 50 
μg/mL HOL-18 and 20 mM GlcNAc.
Fig. 5. Internalization of HOL-18 into four types of human cancer cells. Cells were treated with 
FITC-labeled HOL-18 (25 μg/mL) for 2 h at 37 °C. A: HeLa; B: MCF-7; C: T47D; D: Caco-2. Nuclei 
were visualized by DAPI staining. Scale bar: 25 μm.
Fig. 6. Cytotoxic effects of HOL-18 against four types of cancer cells. A: Cells were treated 
with HOL-18 at various concentrations (0-100 μg/mL) for 48 h, and viability was determined by 
WST-8 assay. In comparison with untreated (control) cells, HOL-18 treatment caused dose-dependent 
reduction of cance cell viability. Values for HeLa, MCF-7, T47D, and Caco-2 are shown respectively 
by striped, black, white, and dotted bars.　B: Inhibition of cytotoxic effect of 50 μg/mL HOL-18 on 
HeLa by addition of Glc, GlcNAc, Man, and ManNAc (each 20 mM). All data shown are mean ± SE 
(n= 3). *p< 0.05.
Fig. 7. Effects of HOL-18 on phosphorylation and expression levels of ERK1/2 and caspase-3 in 
HeLa. Cells (4×105 in each experiment) were treated with various concentrations of HOL-18 as 
shown, and activation levels were evaluated by western blotting of lysates. Experiments were 
performed in triplicate.
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